Telehealth Platform Build Costs Hit $400K for Enterprise Scale—New M&A Data Reshapes Buy Decisions

Build Cost Benchmarks Create Hard Budget Floors

Forasoft published 2026 telehealth platform development cost tiers that function as current market pricing for custom or semi-custom enterprise builds. The numbers provide concrete reference points for budget planning and vendor negotiations.

Tier 1 MVP (single specialty, limited integration): $40K–$90K build cost, 12–16 weeks. Includes web and responsive mobile, one-on-one video, scheduling, secure messaging, lightweight EMR, e-prescribing, and HIPAA controls. Designed for fewer than 10 clinicians and under 5,000 patients.

Tier 2 EHR-integrated platform: $120K–$280K build cost. Targets 10–50 clinicians and up to 50,000 patients in year one. Includes direct integration with Epic, Oracle Health, Athenahealth, and eClinicalWorks, often via aggregators like Redox or 1upHealth to avoid full enterprise complexity.

Tier 3 enterprise, multi-tenant health-system scale: $400K+ build cost, 9–14 months. Features native iOS and Android apps, multi-tenant white-label architecture, HITRUST CSF compliance, deep Epic App Orchard listing, and self-hosted media stack.

Ongoing infrastructure cost for a 5,000-patient direct-primary-care platform runs $1,500–$5,000 per month on AWS HIPAA. A 50,000 monthly active user health-system tenant costs $10,000–$50,000+ per month.

These benchmarks sit alongside off-the-shelf and configurable platforms from Teladoc Health, Amwell, MDLIVE, and Doxy.me. For organizations already invested in Epic, Oracle Health, Athenahealth, or eClinicalWorks, the Tier 2 and Tier 3 numbers establish a price floor under full-stack custom builds. If a vendor quotes more than $400K for a limited-scope build without multi-tenant scale, HITRUST compliance, or deep EHR integration, these benchmarks provide hard data to challenge pricing.

Conversely, if a health system can secure a multi-year contract with a mature platform vendor for less than the three-to-five-year total cost of ownership implied by a $400K+ build plus $10K–$50K+ monthly run-rate, the case for buying instead of building strengthens.

M&A Activity Accelerates Vendor Consolidation

Drake Star reports 53 telehealth M&A deals in 2024, up from 42 in 2023. Rock Health tracked 37 digital health deals in Q1 2024, 28 in Q2, and 21 in Q3, compared to a 2023 quarterly average of 37 deals. The slowdown mid-year indicates softer deal flow but continued consolidation.

The M&A pattern is capability-driven. Acquirers are adding new service lines such as behavioral health, diagnostics, and pharmacy, plus clinical depth, distribution, and data and AI integration. Teladoc Health paid $600M for InTouch Health to strengthen its enterprise telehealth offering. MDLIVE acquired asynchronous care and triage player Bright.md in 2023.

Teladoc Health, Amwell, MDLIVE (owned by Evernorth), and a cluster of behavioral health platforms are consolidating specialized capabilities. Single-feature or video-only platforms face increasing difficulty competing at enterprise scale.

What This Means for Platform Selection

The 53 deals in 2024 confirm that vendor landscapes will continue to change during the lifecycle of a telehealth deployment. Buyers should expect M&A to affect their stack—a niche telepsychiatry provider or triage tool may be acquired and re-bundled—and bake that into contract clauses and integration strategies. Data portability and API guarantees become critical.

Acquirers are chasing care orchestration: triage, diagnosis, treatment, and follow-up in a single workflow. Enterprises that pick single-module vendors may face pressure to migrate to integrated platforms mid-contract or accept the cost of maintaining multiple point integrations.

The cost benchmarks tie scale explicitly to budget. Fewer than 10 clinicians and under 5,000 patients maps to Tier 1. Ten to 50 clinicians and up to 50,000 patients maps to Tier 2. More than 50 clinicians and multi-tenant scenarios require Tier 3. That mapping makes it easier for governance bodies to limit risk by locking scope—insisting on Tier 1 or Tier 2 launches first—before committing to Tier 3 capital spend.

What to Watch

If M&A activity continues at 2024 levels, expect further vendor exits and product sunset announcements in 2025. Organizations that selected niche or single-feature telehealth vendors in 2022–2023 should audit their contracts now for change-of-control clauses and data export rights.

The gap between Tier 2 ($120K–$280K) and Tier 3 ($400K+) build costs creates a decision point for mid-sized health systems. Those that can constrain scope to 50 clinicians or fewer and a single EHR integration gain access to a significantly cheaper deployment path. Organizations that cannot constrain scope should model total cost of ownership over five years—including run-rate infrastructure costs—against vendor subscription pricing before committing to custom builds.